Approaches to anticancer therapy based on modulation of DNA methylation
Автор: Maksimova V.P., Makus J.V., Popova V.G., Usalka O.G., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Обзоры
Статья в выпуске: 4 т.23, 2024 года.
Бесплатный доступ
Background. DNA methylation is a crucial mechanism of epigenetic regulation of transcription. Disturbances in DNA methylation mechanism are associated with various malignancies such as acute myeloid leukaemia, breast cancer, prostate cancer, etc. Influencing the functional status of DNA methyltransferases (DNMTs) enzymes and TET family proteins (TETs), which regulate DNA methylation and demethylation, is the basis of epigenetic anticancer therapy approach. In this review, we have considered the challenges and prospects of nucleoside and non-nucleoside inhibitors of DNMTs as well as TETs inhibitors. The results of clinical trials on the efficacy of DNMTs inhibitors used individually and as part of combination chemotherapy conducted over the last 15 years are also evaluated. Material and Methods. Sources were searched in PubMed, ScienceDirect, Web of Science, eLibrary, CyberLeninka. More than 700 publications were used in the analysis, but the review included mainly works of the last 10 years. A number of articles published earlier than 2015 were used for historical reference.
Antitumour therapy, dna methylation, dnmts inhibitors, tets inhibitors, clinical trials
Короткий адрес: https://sciup.org/140307080
IDR: 140307080 | DOI: 10.21294/1814-4861-2024-23-4-125-140